Wendy Guy - 01 Oct 2025 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role: Chief Administrative Officer
Signature: /s/ Wendy Guy by John J. Wolfel, as Attorney-in-Fact
Issuer symbol: PCSA
Transactions as of: 01 Oct 2025
Net transactions value: $0
Form type: 4
Filing time: 03 Oct 2025, 16:33:01 UTC
Previous filing: 28 Jul 2025
Next filing: 04 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Guy Wendy	Chief Administrative Officer	C/O PROCESSA PHARMACEUTICALS, INC., 601 21ST STREET SUITE 300, VERO BEACH	/s/ Wendy Guy by John J. Wolfel, as Attorney-in-Fact	03 Oct 2025	0001799360

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PCSA	Restricted Stock Units	Award	$0	+50,000		$0.000000	50,000	01 Oct 2025	Common Stock	50,000	$0.000000	Direct	F1
transaction	PCSA	Stock Options (Right to Buy)	Award	$0	+150,000		$0.000000	150,000	01 Oct 2025	Common Stock	150,000	$0.1980	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028.
F2	Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.